HALEOS LABS LIMITED (HALEOSLABS) — Board Meeting | 2 June 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Haleos Labs reconstituted its board sub-committees effective May 29, 2026, following director changes. The Audit Committee now includes P. Sarath Kumar as Chairman and TWSN Murthy as a member. The Nomination and Remuneration Committee appointed Mannam Malakondaiah as Chairman with P. Sarath Kumar and Srinivas Samavedam as members. The CSR Committee is chaired by TWSN Murthy with Mannam Malakondaiah and TV Praveen as members. The Stakeholder Relationship Committee features P. Sarath Kumar as Chairman with TWSN Murthy and Talluri Venkata Praveen as members. These appointments reflect board restructuring after recent composition changes.

📄 View Original Announcement (PDF)

About HALEOS LABS LIMITED (HALEOSLABS)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹460.98 Cr P/E: 29.2 ROE: 7.8% ROCE: 10.0% Div Yield: 0.10%

View full HALEOSLABS stock details →

📡 Get AI alerts when HALEOSLABS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track HALEOSLABS — Free

📊 More HALEOSLABS filings

See all HALEOSLABS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when HALEOSLABS files new disclosures

Track HALEOSLABS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track HALEOSLABS — Free

Free account · 2 AI queries/day